T.T. Haug et al. / Journal of Organometallic Chemistry 694 (2009) 510–514
513
143 (34), 128 (35), 115 (20). HRMS Calc. for C16H20O: 228.1514.
Found: 228.1511.
128.3, 128.4, 131.6, 150.0; MS (70 eV) m/z (%): 228 (8) [M+], 213
(17), 171 (100), 152 (15), 128 (16). HRMS Calc. for C16H20O:
228.1514. Found: 228.1515.
4.3.5. (E/Z)-(5-Methoxypent-3-en-1-yne-1,5-diyl)dibenzene (19)
1H NMR (250 MHz, CDCl3) d 3.37 (s, 3H, E-isomer), 3.44 (s, 2.1H,
Z-isomer), 7.73 (dd, J = 1.1, 6.5 Hz, 1H, E-isomer), 5.48 (d, J = 8.9 Hz,
0.7H, Z-isomer), 5.88–6.11 (m, 1H E-isomer, 1.4H Z-isomer), 6.29
(dd, J = 6.5 15.8 Hz, 1H, E-isomer), 7.29–7.52 (m, 10H E-isomer,
7H Z-isomer); 13C NMR (E-isomer, 62.9 MHz, CDCl3) d 56.7, 83.7,
87.5, 90.6, 111.2, 123.3, 127.1, 128.1, 128.4, 128.6, 128.7, 131.7,
141.0, 143.3. MS (70 eV) m/z (%): 248 (32) [M+], 233 (100), 215
(66), 202 (38). HRMS Calc. for C18H16O: 248.1201. Found:
248.1203.
4.3.11. (E)-(5-Methoxy-4-methylpent-3-en-1-ynyl)benzene (31)
1H NMR (250 MHz, CDCl3) d 1.97 (s, 3H), 3.34 (s, 3H), 3.94 (d,
J = 0.5 Hz, 2H), 5.75 (d, J = 1.3 Hz, 1H), 7.29–7.34 (m, 3H), 7.43–
7.46 (m, 2H); 13C NMR (90.6 MHz, CDCl3) d 16.9, 58.2, 76.5, 86.8,
93.4, 106.5, 123.9, 128.1, 128.4, 131.5, 147.9. MS (70 eV) m/z (%):
186 (32) [M+], 171 (100), 128 (52), 115 (38). HRMS Calc. for
C13H14O: 186.1045. Found: 186.1044.
4.3.12. (E)-(5-Isopropoxy-4-methylpent-3-en-1-ynyl)benzene (33)
1H NMR (250 MHz, CDCl3) d 1.18 (d, J = 6.0 Hz, 6H), 1.97 (s, 3H),
3.56–3.66 (m, 1H), 3.98 (d, J = 0.8 Hz, 2H), 5.78 (d, J = 1.3 Hz, 1H),
7.29–7.32 (m, 3H), 7.42–7.46 (m, 2H); 13C NMR (90.6 MHz, CDCl3)
d 17.0, 22.2, 71.2, 71.9, 87.1, 93.2, 105.8. 124.0, 128.0, 128.4, 131.5,
148.8. MS (70 eV) m/z (%): 214 (32) [M+], 199 (15), 172 (38), 157
(58), 128 (100). HRMS Calc. for C15H18O: 214.1358. Found:
214.1359.
4.3.6. (E/Z)-(5-Isopropoxypent-3-en-1-yne-1,5-diyl)dibenzene (20)
1H NMR (250 MHz, CDCl3) d 1.17 (d, J = 6.2 Hz, 3 H, E-isomer),
1.22–1.28 (m, 3H E-isomer, 4.8H Z-isomer), 3.66–3.85 (m, 1H E-
isomer, 0.8H Z-isomer), 4.97 (dd, J = 1.3, 6.3 Hz, 1H, E-isomer),
5.64 (d, J = 9.0 Hz, 0.8H, Z-isomer), 5.82–6.10 (m, 1H E-isomer,
1.6H Z-isomer), 6.31 (dd, J = 6.3, 16.0 Hz, 1H, E-isomer), 7.28–
7.50 (m, 10H E-isomer, 8H Z-isomer); 13C NMR (E-isomer,
62.9 MHz, CDCl3) d 22.3, 22.6, 69.3, 79.0, 85.9, 87.7, 95.7, 110.5,
123.4, 126.5, 127.9, 128.3, 128.6, 131.6, 141.2, 144.5. MS (70 eV)
m/z (%): 276 (18) [M+], 233 (100), 215 (57), 205 (45). HRMS Calc.
for C20H20O: 276.1514. Found: 276.1510.
4.3.13. (Z/E)-1-(5-Methoxy-3-methylpent-3-en-1-ynyl)benzene (34)
1H NMR (CDCl3, 360 MHz) d 1.93 (s, 0.2H E-isomer), 1.99 (s,
1H Z-isomer), 3.37 (s, 3H Z-isomer, 0.6H E-isomer), 4.06 (d,
J = 6.6 Hz, 0.8H E-isomer), 4.21 (d, J = 6.8 Hz, 2H Z-isomer),
5.84–5.88 (m, 1H Z-isomer), 6.02–6.09 (m, 0.2H E-isomer),
7.31–7.33 (m, 3H Z-isomer, 0.6H E-isomer), 7.43–7.46 (m, 2H Z-
isomer, 0.4H E-isomer); 13C NMR (Z-isomer, CDCl3, 90 MHz) d
23.3, 58.2, 71.0, 87.8, 94.3, 121.9, 128.4, 128.4, 128.5, 131.6,
133.5; MS (70 eV) m/z (%): 186 (3) [M+], 171 (20), 158 (20),
142 (100), 128 (67), 115 (30).
4.3.7. (E)-2-Isopropoxy-5-methylundec-3-en-5-yne (22)
1H NMR (360 MHz, CDCl3) d 0.90 (t, J = 7.2 Hz, 3H), 1.10 (d,
J = 6.1 Hz, 3H), 1.13 (t, J = 6.1 Hz, 3H), 1.21 (d, J = 6.6 Hz, 3H),
1.28ꢀ1.42 (m, 4H), 1.48ꢀ1.56 (m, 2H), 2.29 (td, J = 7.2 Hz,
J = 2.0 Hz, 2H), 3.62 (sep, J = 6.1 Hz, 1H), 3.91ꢀ4.00 (m, 1H), 5.61
(dd, J = 15.9 Hz, J = 1.1 Hz, 1H), 5.94 (dd, J = 15.9 Hz, J = 7.0 Hz,
1H); 13C NMR (90.6 MHz, CDCl3) d 14.0, 19.5, 21.7, 22.0, 22.3,
23.3, 28.5, 31.2, 68.7, 72.9, 78.5, 91.0, 110.5, 144.6; MS (70 eV)
m/z (%): 208 (5), 151 (14), 109 (100), 95 (26), 81 (27). HRMS Calc.
for C14H24O: 208.1827. Found: 208.1828.
4.3.14. (Z/E)-1-(5-Isopropoxy-3-methylpent-3-en-1-ynyl)benzene
(35)
1H NMR (CDCl3, 360 MHz) d 1.19 (d, J = 6.1 Hz, 6H Z-isomer, 2H
E-isomer), 1.92 (m, 0.6H E-isomer), 1.97 (d, J = 1.1 Hz, 3H Z-iso-
mer), 3.65–3.69 (m, 1H Z-isomer, 0.2H E-isomer), 4.09 (dd,
J = 0.6 Hz, J = 6.8 Hz, 0.4H E-isomer), 4.25 (dd, J = 1.1 Hz,
J = 6.8 Hz, 2H Z-isomer), 5.85–5.89 (m, 1H Z-isomer), 6.00–6.10
(m, 0.2H, E-isomer), 7.28–7.34 (m, 3H Z-isomer, 0.6H E-isomer),
7.41–7.45 (m, 2H Z-isomer, 0.4H E-isomer); 13C NMR (Z-isomer,
CDCl3, 90 MHz) d 22.3, 23.3, 66.6, 70.9, 87.9, 94.1, 121.1, 123.5,
128.4, 128.5, 131.6, 134.5; MS (70 eV) m/z (%): 213 (1), 207 (10),
187 (30), 145 (100), 129 (28), 115 (15).
4.3.8. (E/Z)-(1-isopropoxypent-2-en-4-ynyl)benzene (26)
1H NMR (360 MHz, CDCl3) d 1.14 (d, J = 6.1 Hz, 3H E-isomer),
1.19–1.22 (m, 3H E-isomer, 1.8H Z-isomer), 1.23 (d, J = 6.1 Hz 3H
Z-isomer), 2.87 (d, J = 2.3 Hz, 1H E-isomer), 3.19 (dd, J = 2.3, 0.9,
0.6H Z-isomer), 3.60–3.69 (m, 1H E-isomer), 3.70–3.79 (m, 0.6H
Z-isomer), 4.91 (dd, J = 6.0, 1.2, 1H, E-isomer), 5.53–5.56 (m, 1H,
E-isomer), 5.58–5.62 (m, 0.6H, Z-isomer), 5.69–5.75 (m, 1H, E-iso-
mer), 6.05–6.11 (m, 0.6H, Z-isomer), 6.31 (dd, J = 15.9, 6.0, 1H, E-
isomer), 7.24–7.44 (m, 5H E-isomer, 3H Z-isomer); 13C NMR
(90.6 MHz, CDCl3) d 22.2, 22.6, 69.4, 78.1, 78.7, 82.7, 109.2, 126.5,
127.1, 127.9, 128.7, 140.8, 146.3; MS (70 eV) m/z (%): 200 (5)
[M+], 185 (5), 157 (57), 141 (76), 129 (83), 115 (100), 105 (54),
91 (30), 77 (32), 63 (14), 51 (19).
4.3.15. (E)-4-Methyl-N-(2-methyl-5-phenylpent-2-en-4-
ynyl)benzenesulfonamide (36)
1H NMR (360 MHz, CDCl3) d 1.90 (s, 3H), 2.43 (s, 3H), 3.62 (d,
J = 6.4 Hz, 2H), 4.45 (s, br, 1H), 5.63–5.64 (m, 1H), 7.28–7.34 (m,
5H), 7.38–7.44 (m, 2H), 7.75–7.77 (m, 2H); 13C NMR (90.6 MHz,
CDCl3) d 17.6, 21.7, 49.7, 86.2, 94.1, 108.1, 123.5, 127.3, 128.3,
128.5, 129.9, 131.5, 137.1, 143.8, 145.6; MS (70 eV): m/z (%):348
(100) [M++Na], 333 (29), 305 (9), 193 (10), 139 (25). HRMS Calc.
for C19H19N (M+ꢀ64): 261.1518. Found: 261.1517.
4.3.9. (E)-1-(5-Methoxy-5-methylhex-3-en-1-ynyl)benzene (28)
1H NMR (360 MHz, CDCl3) d 1.32 (s, 6H), 3.21 (s, 3H), 5.84 (d,
J = 16.4 Hz, 1H), 6.21 (d, J = 16.4 Hz, 1H), 7.28ꢀ7.33 (m, 3H),
7.41ꢀ7.47 (m, 2H); 13C NMR (90.6 MHz, CDCl3) d = 25.7, 50.8,
75.2, 87.6, 90.1, 109.6, 123.5, 128.3, 128.4, 131.6, 148.7; MS
(70 eV) m/z (%): 200 (25) [M+], 185 (100), 170 (23), 152 (38), 141
(14). HRMS Calc. for C14H16O: 200.1201. Found: 200.1201.
4.3.16. (Z)-2-(3-Methyl-5-phenylpent-2-en-4-ynyl)furan (37)
1H NMR (CDCl3, 360 MHz) d1.96–2.00 (m, 3H Z-isomer, 1H E-iso-
mer), 3.49 (d, J = 7.3 Hz, 0.6H E-isomer), 3.69 (d, J = 7.3 Hz, 2H Z-
isomer), 5.87 (qt, J = 1.6 Hz, 7.3 Hz, 1H Z-isomer), 6.04–6.05 (m,
1H Z-isomer), 6.08–6.13 (m, 0.3H E-isomer), 6.30 (dd, J = 2.0 Hz,
3.2 Hz, 1H, Z-isomer), 7.29–7.35 (m, 2H Z-isomer, 0.6H E-isomer),
7.42–7.47 (m, 3H, Z-isomer, 1H E-isomer); 13C NMR (Z-isomer,
CDCl3, 90.6 MHz) d 23.2, 29.9, 88.3, 93.8, 105.4, 110.4, 120.3,
123.6, 128.3, 128.4, 131.7, 132.5, 141.3, 154.1; MS (70 eV) m/z
(%): 222 (30) [M+], 207 (100) [M+ꢀCH3], 178 (100).
4.3.10. (E)-1-(5-Isopropoxy-5-methylhex-3-en-1-ynyl)benzene (29)
1H NMR (360 MHz, CDCl3) d 1.14 (d, J = 6.2 Hz, 6H), 1.32 (s, 6H),
3.70 (sep, J = 6.2 Hz, 1H), 5.82 (d, J = 16.4 Hz, 1H), 6.28 (d,
J = 16.4 Hz, 1H), 7.28ꢀ7.35 (m, 3H), 7.41ꢀ7.46 (m, 2H); 13C NMR
(90.6 MHz, CDCl3) d 25.2, 26.9, 65.3, 75.3, 87.8, 89.9, 108.9, 123.5,